Literature DB >> 11836012

Alzheimer's disease through the eye of a mouse. Acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize.

John E Morley1, Sue A Farr, Vijaya B Kumar, William A Banks.   

Abstract

There is now ample evidence that beta-amyloid proteins decrease memory. The SAMP8 mouse (P8) develops an early decline in the ability to learn and to retain new information. The studies reviewed here suggest that this is due to overproduction of beta-amyloid. Both antibodies to beta-amyloid and specific antisense to the amyloid precursor protein reverse these deficits in the P8 mouse. This antisense can cross the blood brain barrier. It is hypothesized that the overproduction of beta-amyloid leads to a decline in Delta(9) desaturase activity with an alteration in membrane fatty acids. This results in altered membrane mobility leading to a decline in neurotransmitter activity and a decreased release of acetylcholine. This decreased cholinergic activity results in a decreased ability of the P8 mouse to learn and retain new information.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836012     DOI: 10.1016/s0196-9781(01)00630-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

1.  Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.

Authors:  Naoko Nonaka; Susan A Farr; Tomoya Nakamachi; John E Morley; Masanori Nakamura; Seiji Shioda; William A Banks
Journal:  Peptides       Date:  2012-06-09       Impact factor: 3.750

Review 2.  Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

Authors:  William A Banks
Journal:  Adv Drug Deliv Rev       Date:  2011-12-17       Impact factor: 15.470

3.  Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments.

Authors:  Abbas K Ali; William A Banks; Vijaya B Kumar; Gul N Shah; Jessica L Lynch; Susan A Farr; Melissa A Fleegal-DeMotta; John E Morley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-16       Impact factor: 6.053

4.  SAMP8 mice have altered hippocampal gene expression in long term potentiation, phosphatidylinositol signaling, and endocytosis pathways.

Authors:  Harvey J Armbrecht; Akbar M Siddiqui; Michael Green; Susan A Farr; Vijaya B Kumar; William A Banks; Ping Patrick; Gul N Shah; John E Morley
Journal:  Neurobiol Aging       Date:  2013-08-19       Impact factor: 4.673

5.  Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.

Authors:  Laura B Jaeger; Shinya Dohgu; Rukhsana Sultana; Jessica L Lynch; Joshua B Owen; Michelle A Erickson; Gul N Shah; Tulin O Price; Melissa A Fleegal-Demotta; D Allan Butterfield; D Allan Butterfiled; William A Banks
Journal:  Brain Behav Immun       Date:  2009-02-06       Impact factor: 7.217

6.  Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.

Authors:  William A Banks; Susan A Farr; John E Morley; Kathy M Wolf; Valeria Geylis; Michael Steinitz
Journal:  Exp Neurol       Date:  2007-05-22       Impact factor: 5.330

7.  Current neuroimaging techniques in Alzheimer's disease and applications in animal models.

Authors:  Linda Zhang; Raymond Chuen-Chung Chang; Leung-Wing Chu; Henry Ka-Fung Mak
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

8.  Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease.

Authors:  W A Banks; S M Robinson; S Verma; J E Morley
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection.

Authors:  Hei-Jen Huang; Yen-Hsu Chen; Keng-Chen Liang; Yu-Syuan Jheng; Jhih-Jhen Jhao; Ming-Tsan Su; Guey-Jen Lee-Chen; Hsiu Mei Hsieh-Li
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Memantine combined with environmental enrichment improves spatial memory and alleviates Alzheimer's disease-like pathology in senescence-accelerated prone-8 (SAMP8) mice.

Authors:  Jingde Dong; Mi Zhou; Xiaoqiang Wu; Mingyang Du; Xiaoshan Wang
Journal:  J Biomed Res       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.